NXXI Inc (fka NXXIQ)

[JimProfit]

Nutrition 21 Announces Formation of Scientific Advisory Board
Wednesday April 18, 9:00 am ET

PURCHASE, N.Y.--(BUSINESS WIRE)--Nutrition 21, Inc. (NASDAQ: NXXI - News), a leading developer and marketer of chromium-based, selenium-based and omega-3 fish oil-based nutritional supplements, today announced the formation of its Scientific Advisory Board that will provide guidance on research and future product development.

The members of the Scientific Advisory Board are Dr. Robert Golden, Dean of the School of Medicine and Public Health and Vice Chancellor for Medical Affairs at the University of Wisconsin; Dr. Louis Ignarro, 1998 recipient of the Nobel Prize in Physiology or Medicine, Distinguished Professor of Pharmacology in the Department of Molecular and Medical Pharmacology, UCLA School of Medicine; Dr. Francine Kaufman, former president of the American Diabetes Association, Director of the Comprehensive Childhood Diabetes Center and Head of the Center for Endocrinology, Diabetes and Metabolism at Children's Hospital Los Angeles; and Dr. Ron Krauss, Senior Scientist and Director of Atherosclerosis Research at the Children's Hospital Oakland Research Institute, Guest Senior Scientist at the Department of Genome Sciences at Lawrence Berkeley National Laboratory and Adjunct Professor, Department of Nutritional Sciences University of California, Berkeley.

"Each of these distinguished members represents expertise and leadership in their respective areas and we are honored to have them be a part of our Scientific Advisory Board," said Paul Intlekofer, president and CEO of Nutrition 21. "The formation of this board will help ensure that Nutrition 21 is at the forefront of new scientific advances. This is another milestone in our continued growth and development as company committed to providing quality products backed by research."

More information on the Scientific Advisory Board members can be found at: http://www.nutrition21.com/About/Scientific/default.aspx

About Nutrition 21

Nutrition 21 is a nutritional bioscience company and the maker of chromium picolinate-based, selenium and omega-3 fish oil-based supplements with health benefits substantiated by clinical research. Nutrition 21 holds over 30 patents for nutrition products and uses. The company markets Chromax® chromium picolinate, which is the most-studied form of the essential mineral chromium. Chromax, a supplement for healthy and pre-diabetic people that promotes insulin health and helps improve blood sugar metabolism, cardiovascular disease, control cravings and fight weight gain, is now available through food, drug and mass retailers nationwide. Another chromium picolinate-based supplement developed and marketed by Nutrition 21 is Diachrome®, a proprietary, non-prescription, insulin sensitizer for people with type 2 diabetes. It is sold in select drug retailers nationwide. Nutrition 21 also markets Selenomax®, a high selenium yeast supplement that stimulates and protects the immune system by supporting antibody production and preventing free-radical damage.

Selenomax is available at CVS/pharmacy in all its 6,200 retail stores nationwide, including PharmaCare Specialty Pharmacy locations, and on www.cvs.com. The Company is the exclusive importer of Icelandic fish oils, including omega-3 fatty acids, which are manufactured to pharmaceutical standards and sold under the Iceland Health® brand. More information is available at http://www.nutrition21.com/.


Contact:

Nutrition 21, Inc.
Maryrose Lombardo, 914-701-4525

Source: Nutrition 21, Inc.